LeVeen H H, Wapnick S, Diaz C, Grosberg S, Kinney M
Curr Probl Surg. 1979 Feb;16(2):1-61. doi: 10.1016/s0011-3840(79)80001-5.
Patients with refractory ascites and HRS should be considered to present an urgent indication for peritoneovenous shunting. The shunt offers a method of continuous reinfusion of ascitic fluid which corrects avid sodium retention, oliguria and azotemia. Severe encephalopathy, jaundice or peritoneal sepsis--common complications of cirrhosis--contraindicate installation of the shunt before improvement occurs. Associated cardiac disease does not contraindicate the use of the shunt provided that ascitic fluid is removed at the time of operation and large amounts of diuretics are used. This operation has also proved useful in ascites attributed to causes other than cirrhosis. The main complications include disseminated intravascular coagulopathy, hepatic coma and sepsis in a few patients. Results of a randomized prospective study indicate that the shunt should probably be considered in patients with diet-resistant massive ascites even before they prove to be refractory to diuretic therapy.
顽固性腹水和肝肾综合征患者应被视为腹膜静脉分流术的紧急适应证。该分流术提供了一种持续回输腹水的方法,可纠正严重的钠潴留、少尿和氮质血症。严重肝性脑病、黄疸或腹膜感染(肝硬化的常见并发症)在病情改善之前是安装分流术的禁忌证。伴有心脏疾病并非使用分流术的禁忌证,前提是在手术时清除腹水并使用大量利尿剂。该手术在非肝硬化原因引起的腹水中也已证明有效。主要并发症包括弥散性血管内凝血、肝昏迷,少数患者会发生感染。一项随机前瞻性研究结果表明,对于对饮食控制无效的大量腹水患者,即使在证明对利尿治疗无效之前,也可能应考虑进行分流术。